Consolidating Gains and Accelerating Efforts to Control and Eliminate Malaria in Developing Countries, Particularly in Africa, by 2015

A/RES/65/273No PDF available

Who created this mandate?

A Resolution of the General Assembly, under agenda item 122001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in Africa, published in 2011.

What other versions does this mandate have?

10 versions · 2011–2021

This is an older version — the most recent is A/RES/75/328

2021A/RES/75/328Consolidating gains and accelerating efforts to control and eliminate malaria in developing countries, particularly in Africa, by 2030LatestCompare with previous version
2020A/RES/74/305Consolidating gains and accelerating efforts to control and eliminate malaria in developing countries, particularly in Africa, by 2030Compare with previous version
2019A/RES/73/337Consolidating gains and accelerating efforts to control and eliminate malaria in developing countries, particularly in Africa, by 2030Compare with previous version
2018A/RES/72/309Consolidating gains and accelerating efforts to control and eliminate malaria in developing countries, particularly in Africa, by 2030Compare with previous version
2017A/RES/71/325Consolidating gains and accelerating efforts to control and eliminate malaria in developing countries, particularly in Africa, by 2030Compare with previous version

Versions are identified automatically by matching titles within the same organ (~97% accuracy on a manual audit).

What subjects does this mandate have?

15 topics

Africa Disease Control Disease Prevention Health Personnel Health Programmes Health Services International Decades Malaria Maternal and Child Health Partnership Preventive Medicine Research and Development Resources Allocation Vaccines Vector-Borne Diseases

What does this mandate say?

32 operative paragraphs

Welcomes the report prepared by the World Health Organization, and calls for support for the recommendations contained therein;

Encourages Member States, relevant organizations of the United Nations system, international institutions, non-governmental organizations, the private sector and civil society to continue to observe World Malaria Day in order to raise public awareness of and knowledge about the prevention, control and treatment of malaria as well as the importance of meeting the Millennium Development Goals, and stresses the importance of engaging local communities in this regard;

Encourages the Special Envoy of the Secretary-General for Malaria to continue raising the issue in collaboration with other United Nations organizations already working on those issues on the international political and development agendas and to work with national and global leaders to help to secure the political will, the partnerships and the funds to drastically reduce malaria deaths by 2015 through increased access to prevention, diagnosis and treatment, especially in Africa;

Welcomes the increased funding for malaria interventions and for research and development of preventive, diagnostic and control tools from the international community, through funding from multilateral and bilateral sources and from the private sector, as well as by making predictable financing available through appropriate and effective aid modalities and in-country health financing mechanisms aligned with national priorities, which are key to strengthening health systems, including malaria surveillance, and promoting universal and equitable access to high-quality malaria prevention, diagnostic and treatment services, and notes in this regard that a high level of external assistance per person at risk for malaria is associated with a decrease in the incidence of the disease;

Urges the international community, together with United Nations agencies and private organizations and foundations, to support the implementation of the Global Malaria Action Plan, including through support for programmes and activities at the country level in order to achieve internationally agreed targets on malaria;

Calls upon the international community to continue to support the secretariat of the Roll Back Malaria Partnership and partner organizations, including the World Health Organization, the World Bank and the United Nations Children’s Fund, as vital complementary sources of support for the efforts of malaria-endemic countries to combat the disease;

Appeals to the international community to work in a spirit of cooperation towards effective, increased, harmonized, predictable and sustained bilateral and multilateral assistance to combat malaria, including support for the Global Fund to Fight AIDS, Tuberculosis and Malaria, in order to assist States, in particular malaria-endemic countries, to implement sound national health and sanitation plans, including malaria control strategies and integrated management of childhood illnesses, in a sustained and equitable way that, inter alia, contributes to strengthening health system development approaches at the district level;

Appeals to the malaria partners to resolve the financial supply chain and delivery bottlenecks that are responsible for stock-outs of long-lasting insecticide-treated nets, rapid diagnostic tests and artemisinin-based combination therapies at the national level, whenever they occur, including through the strengthening of malaria programme management at the country level;

Welcomes the contribution to the mobilization of additional and predictable resources for development by voluntary innovative financing initiatives taken by groups of Member States, and in this regard notes the International Drug Purchase Facility, UNITAID, the International Finance Facility for Immunization, the advance market commitments for vaccines, the Global Alliance for Vaccines and Immunization and phase one of the Affordable Medicines Facility for Malaria, and takes note of the work of the Leading Group on Innovative Financing for Development and its special task force on innovative financing for health which was set up recently;

Urges malaria-endemic countries to work towards financial sustainability, to increase, to the extent possible, domestic resource allocation to malaria control and to create favourable conditions for working with the private sector in order to improve access to good-quality malaria services;

Urges Member States to assess and respond to the needs for integrated human resources at all levels of the health system, in order to achieve the targets of the Abuja Declaration on Roll Back Malaria in AfricaError: Reference source not found and the internationally agreed development goals, including the Millennium Development Goals, to take actions, as appropriate, to effectively govern the recruitment, training and retention of skilled health personnel, and to give particular focus to the availability of skilled personnel at all levels to meet technical and operational needs as increased funding for malaria control programmes becomes available;

Calls upon the international community, inter alia, by helping to meet the financial needs of the Global Fund to Fight AIDS, Tuberculosis and Malaria and through country-led initiatives with adequate international support, to intensify access to affordable, safe and effective antimalarial combination treatments, intermittent preventive treatment in pregnancies, adequate diagnostic facilities, long-lasting insecticide-treated mosquito nets, including, where appropriate, through the free distribution of such nets and, where appropriate, to insecticides for indoor residual spraying for malaria control, taking into account relevant international rules, including the Stockholm Convention on Persistent Organic Pollutants standards and guidelines;

Requests relevant international organizations, in particular the World Health Organization and the United Nations Children’s Fund, to assist efforts of national Governments to provide universal access to malaria control interventions to address all at-risk populations, in particular young children and pregnant women, in malaria-endemic countries, particularly in Africa, as rapidly as possible, with due regard to ensuring proper use of those interventions, including long-lasting insecticide nets, and sustainability through full community participation and implementation through the health system;

Calls upon Member States, in particular malaria-endemic countries, with the support of the international community, to establish and/or strengthen national policies and operational plans, with a view to scaling up efforts to achieve internationally agreed malaria targets for 2015, in accordance with the technical recommendations of the World Health Organization;

Commends those African countries that have implemented the recommendations of the Abuja Summit in 2000 to reduce or waive taxes and tariffs for nets and other products needed for malaria control,6 and encourages other countries to do the same;

Calls upon United Nations agencies and their partners to continue to provide the technical support necessary to build and enhance the capacity of Member States to implement the Global Malaria Action Plan and meet the internationally agreed goals, including the Millennium Development Goals;

Expresses its concern about the increase in resistant strains of malaria in several regions of the world, and calls upon Member States, with support from the World Health Organization and other partners, to implement the Organization’s Global Plan for Artemisinin Resistance Containment to strengthen and implement surveillance systems for drug and insecticide resistance, and upon the World Health Organization to coordinate a global network for the monitoring of drug and insecticide resistance and ensure that drug and insecticide testing is fully operational in order to enhance the use of current insecticide- and artemisinin-based combination therapies, and stresses that the data gathered should be utilized for further research and development of safe and effective therapies;

Urges all Member States to prohibit the marketing and use of oral artemisinin-based monotherapies and to replace them with oral artemisinin-based combination therapies, as recommended by the World Health Organization, and to develop the necessary financial, legislative and regulatory mechanisms in order to introduce artemisinin combination therapies at affordable prices in both public and private facilities;

Recognizes the importance of the development of safe and cost-effective vaccines and new medicines to prevent and treat malaria and the need for further and accelerated research, including into safe, effective and high-quality therapies, using rigorous standards, including by providing support to the Special Programme for Research and Training in Tropical Diseases and through effective global partnerships, such as the various malaria vaccine initiatives and the Medicines for Malaria Venture, where necessary stimulated by new incentives to secure their development and through effective and timely support towards pre-qualification of new antimalarials and their combinations;

Calls upon the international community, including through existing partnerships, to increase investment in and efforts towards research to optimize current tools, develop and validate new, safe and affordable malaria-related medicines, products and technologies, such as vaccines, rapid diagnostic tests, insecticides and delivery modes, to prevent and treat malaria, especially for at-risk children and pregnant women, and testing opportunities for integration in order to enhance effectiveness and delay the onset of resistance;

Calls upon malaria-endemic countries to assure favourable conditions for research institutions, including allocation of adequate resources and development of national policies and legal frameworks, where appropriate, with a view to, inter alia, informing policy formulation and strategic interventions on malaria;

Reaffirms the right to use, to the fullest extent, the provisions contained in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), the Doha Declaration on the TRIPS Agreement and Public Health, the decision of the General Council of the World Trade Organization of 30 August 2003 on the implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, and, when formal acceptance procedures are completed, the amendment to article 31 of the Agreement, which provide flexibilities for the protection of public health, and in particular to promote access to medicines for all and to encourage the provision of assistance to developing countries in this regard, and calls for broad and timely acceptance of the amendment to article 31 of the Agreement, as proposed by the General Council of the World Trade Organization in its decision of 6 December 2005;Error: Reference source not found

Calls upon the international community to support ways to expand access to affordable and safe products and treatments, such as vector control measures, including indoor residual spraying, long-lasting insecticide-treated nets, including through the free distribution of such nets, adequate diagnostic facilities, intermittent preventive treatment in pregnancies and artemisinin-based combination therapy for populations at risk of falciparum malaria infection in endemic countries, particularly in Africa, including through additional funds and innovative mechanisms, inter alia, for the financing and scaling up of artemisinin production and procurement, as appropriate, to meet the increased need;

Welcomes the increased level of public-private partnerships for malaria control and prevention, including the financial and in-kind contributions of private sector partners and companies operating in Africa, as well as the increased engagement of non-governmental service providers;

Encourages the producers of long-lasting insecticide-treated nets to accelerate technology transfer to developing countries, and invites the World Bank and regional development funds to consider supporting malaria-endemic countries in establishing factories to scale up production of long-lasting insecticide-treated nets;

Calls upon Member States and the international community, including malaria-endemic countries, in accordance with existing guidelines and recommendations of the World Health Organization and the requirements of the Stockholm Convention related to the use of DDT, to become fully knowledgeable about the Organization’s technical policies and strategies and the provisions in the Stockholm Convention, including for indoor residual spraying, long-lasting insecticide-treated nets and case management, intermittent preventive treatment for pregnant women and monitoring of in vivo resistance studies to artemisinin-based combination therapy treatment, as well as to increase capacity for the safe, effective and judicious use of indoor residual spraying and other forms of vector control, including quality control measures, in accordance with international rules, standards and guidelines;

Requests the World Health Organization, the United Nations Children’s Fund and donor agencies to provide support to those countries which choose to use DDT for indoor residual spraying so as to ensure that it is implemented in accordance with international rules, standards and guidelines, and to provide all possible support to malaria-endemic countries to manage the intervention effectively and prevent the contamination, in particular, of agricultural products with DDT and other insecticides used for indoor residual spraying;

Encourages the World Health Organization and its member States, with the support of the parties to the Stockholm Convention, to continue to explore possible alternatives to DDT as a vector control agent;

Calls upon malaria-endemic countries to encourage regional and intersectoral collaboration, both public and private, at all levels, especially in education, health, agriculture, economic development and the environment, to advance malaria control objectives;

Calls upon the international community to support the strengthening of health systems, national pharmaceutical policies and national drug regulatory authorities, to monitor and fight against the trade in counterfeit and substandard antimalarial medicines and prevent their distribution and use, and to support coordinated efforts, inter alia, by providing technical assistance to improve surveillance, monitoring and evaluation systems and their alignment with national plans and systems so as to better track and report changes in coverage, the need for scaling up recommended interventions and the subsequent reductions in the burden of malaria;

Urges Member States, the international community and all relevant actors, including the private sector, to promote the coordinated implementation and enhance the quality of malaria-related activities, including via the Roll Back Malaria Partnership, in accordance with national policies and operational plans that are consistent with the technical recommendations of the World Health Organization and recent efforts and initiatives, including, where appropriate, the Paris Declaration on Aid Effectiveness and the Accra Agenda for Action, adopted during the Third High-level Forum on Aid Effectiveness, held in Accra from 2 to 4 September 2008;

Requests the Secretary-General, in close collaboration with the Director-General of the World Health Organization and in consultation with Member States, to report to the General Assembly at its sixty-sixth session on implementation of the present resolution, and specifically on progress towards achieving the 2015 targets of the Abuja Declaration and those of the Global Malaria Action Plan and Millennium Development Goal 6, including identification of best practices and successes, as well as specific challenges limiting the achievement of the targets, and, taking these into account, to provide recommendations to ensure that the targets are reached by 2015.

Paragraph content is machine-extracted from UN documents. For authoritative content, please refer to the official UN document.

No headings found in this document.

Who created this mandate?

What other versions does this mandate have?

What subjects does this mandate have?

What does this mandate say?

Table of contents